Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q3 2016 call → NOWe need to determine if management conveys that current business activity is disproportionately large relative to the company's small size. Look for statements about scale of orders, contracts, or growth relative to company size. In the transcript, management mentions several large orders: Viper follow-on $2.2M, a $4.8M contract, a $1.6M charger award, etc. But are these described as disproportionately large relative to the company's size? The company's quarterly revenue is ~$19.6M. A $4.8M order is about 25% of quarterly revenue, which is significant. However, management does not explicitly say "this is large relative to our size" or "we are small and this is huge." They mention growth percentages, like communication systems up 77% year-over-year, but that's normal reporting. The question asks: does management convey that the business happening now is visibly outgrowing the company's own current size? Look for phrases like "outsized percentage change because the base is still small" or "single customer could rival a meaningful share." Management does mention that new product development sales in communication systems were 83% of sales, double prior year. But that's not about scale relative to company size. They also mention that they are pursuing acquisitions to gain scale, but that's future. The key is whether management explicitly or implicitly states that the current activity is disproportionately large. They mention a $4.8M order, but they don't frame it as "this is huge for us." They just list it as a win. They also mention that they have a dedicated M&A person to find larger targets, but that's about future. The transcript does not contain a statement like "we are a small company and this order is massive relative to our size." The growth percentages are typical. The company has been profitable for eight quarters, but that's not about disproportion. Thus, answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.